Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: A systematic review and meta-analysis

Critical Care

Volumn 18, Issue 2, 2014, Pages

  Ruan, Sheng Yuan ^a,b   Lin, Hsien Ho ^a   Huang, Chun Ta ^b   Kuo, Ping Hung ^b   Wu, Huey Dong ^b   Yu, Chong Jen ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; ATTRIBUTABLE RISK; COHORT ANALYSIS; CORTICOSTEROID THERAPY; EXPLORATORY RESEARCH; HUMAN; INFECTION RISK; INTENSIVE CARE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SYSTEMATIC REVIEW; CONTROLLED CLINICAL TRIAL (TOPIC); PROCEDURES; RESPIRATORY DISTRESS SYNDROME, ADULT; TREATMENT OUTCOME; TRENDS;

ADRENAL CORTEX HORMONES; CONTROLLED CLINICAL TRIALS AS TOPIC; HUMANS; MORTALITY; RESPIRATORY DISTRESS SYNDROME, ADULT; TREATMENT OUTCOME;

EID: 84899925827     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13819     Document Type: Article

References (44)

1. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012, 307:2526-2533.
2. Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012, 122:2731-2740. 10.1172/JCI60331, 3408735, 22850883.
3. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, Scales DC, Stather DR, Li A, Jones A, Gattas DJ, Hallett D, Tomlinson G, Stewart TE, Ferguson ND. Has mortality from acute respiratory distress syndrome decreased over time?: a systematic review. Am J Respir Crit Care Med 2009, 179:220-227. 10.1164/rccm.200805-722OC, 19011152.
4. Meduri GU, Annane D, Chrousos GP, Marik PE, Sinclair SE. Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest 2009, 136:1631-1643.
5. Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, Kariman K, Higgins S, Bradley R, Metz CA, Harris TR, Brigham KL. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987, 317:1565-1570. 10.1056/NEJM198712173172504, 3317054.
6. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006, 354:1671-1684.
7. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007, 131:954-963. 10.1378/chest.06-2100, 17426195.
8. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998, 280:159-165. 10.1001/jama.280.2.159, 9669790.
9. Adhikari N, Burns KE, Meade MO. Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 2004, 4. CD004477.
10. Agarwal R, Nath A, Aggarwal AN, Gupta D. Do glucocorticoids decrease mortality in acute respiratory distress syndrome? A meta-analysis. Respirology 2007, 12:585-590. 10.1111/j.1440-1843.2007.01060.x, 17587427.
11. Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 2008, 336:1006-1009. 10.1136/bmj.39537.939039.BE, 2364864, 18434379.
12. Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med 2009, 37:1594-1603. 10.1097/CCM.0b013e31819fb507, 19325471.
13. Lamontagne F, Briel M, Guyatt GH, Cook DJ, Bhatnagar N, Meade M. Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials. J Crit Care 2010, 25:420-435. 10.1016/j.jcrc.2009.08.009, 19896324.
14. Dos Santos CC. Advances in mechanisms of repair and remodelling in acute lung injury. Intensive Care Med 2008, 34:619-630. 10.1007/s00134-007-0963-x, 18264692.
15. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097. 10.1371/journal.pmed.1000097, 2707599, 19621072.
16. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011, 343:d5928. 10.1136/bmj.d5928, 3196245, 22008217.
17. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
18. Brun-Buisson C, Richard JCM, Mercat A, Thiebaut ACM, Brochard L, . REVA-SRLF A/H1N1v 2009 Registry Group Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011, 183:1200-1206. 10.1164/rccm.201101-0135OC, 21471082, REVA-SRLF A/H1N1v 2009 Registry Group.
19. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA. Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest 1987, 92:1032-1036. 10.1378/chest.92.6.1032, 3315478.
20. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560. 10.1136/bmj.327.7414.557, 192859, 12958120.
21. Weigelt JA, Norcross JF, Borman KR, Snyder WH. Early steroid therapy for respiratory failure. Arch Surg 1985, 120:536-540. 10.1001/archsurg.1985.01390290018003, 3885915.
22. Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988, 138:62-68. 10.1164/ajrccm/138.1.62, 3202402.
23. Annane D, Sebille V, Bellissant E, . Ger-Inf-05 Study Group Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Crit Care Med 2006, 34:22-30. 10.1097/01.CCM.0000194723.78632.62, 16374152, Ger-Inf-05 Study Group.
24. Fowler AA, Hamman RF, Zerbe GO, Benson KN, Hyers TM. Adult respiratory distress syndrome. Prognosis after onset. Am Rev Respir Dis 1985, 132:472-478.
25. Headley AS, Tolley E, Meduri GU. Infections and the inflammatory response in acute respiratory distress syndrome. Chest 1997, 111:1306-1321. 10.1378/chest.111.5.1306, 9149588.
26. Keel JBP, Hauser M, Stocker R, Baumann PC, Speich R. Established acute respiratory distress syndrome: benefit of corticosteroid rescue therapy. Respiration 1998, 65:258-264. 10.1159/000029273, 9730790.
27. Varpula T, Pettila V, Rintala E, Takkunen O, Valtonen V. Late steroid therapy in primary acute lung injury. Intensive Care Med 2000, 26:526-531. 10.1007/s001340051199, 10923725.
28. Song ZF, Guo XH, Wang SY, Xie W, Yin N, Zhang Y, Shan HM, Li WH. Evaluation of glucocorticoid in treatment for patients with acute respiratory distress syndrome. Chinese Crit Care Med 2003, 15:349-353.
29. Lee HS, Lee JM, Kim MS, Kim HY, Hwangbo B, Zo JI. Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome. Ann Thorac Surg 2005, 79:405-410. 10.1016/j.athoracsur.2004.07.079, 15680804.
30. Bajwa EK, Khan UA, Januzzi JL, Gong MN, Thompson BT, Christiani DC. Plasma C-reactive protein levels are associated with improved outcome in ARDS. Chest 2009, 136:471-480. 10.1378/chest.08-2413, 2818414, 19411291.
31. Schellongowski P, Ullrich R, Hieber C, Hetz H, Losert H, Hermann M, Hermann A, Gattringer KB, Siersch V, Rabitsch W, Fuhrmann V, Bojic A, Robak O, Sperr WR, Laczika K, Locker GJ, Staudinger T. A surge of flu-associated adult respiratory distress syndrome in an Austrian tertiary care hospital during the 2009/2010 Influenza A H1N1v pandemic. Wien Klin Wochenschr 2011, 123:209-214. 10.1007/s00508-011-1557-8, 21465083.
32. Linko R, Pettila V, Ruokonen E, Varpula T, Karlsson S, Tenhunen J, Reinikainen M, Saarinen K, Perttila J, Parviainen I, Ala-Kokko T, . FINNH1N1-Study Group Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A(H1N1) infection in Finland. Acta Anaesthesiol Scand 2011, 55:971-979. FINNH1N1-Study Group.
33. Sibbald WJ, Anderson RR, Reid B, Holliday RL, Driedger AA. Alveolo-capillary permeability in human septic ARDS. Effect of high-dose corticosteroid therapy. Chest 1981, 79:133-142. 10.1378/chest.79.2.133, 7460641.
34. Seam N, Meduri GU, Wang HH, Nylen ES, Sun JF, Schultz MJ, Tropea M, Suffredini AF. Effects of methylprednisolone infusion on markers of inflammation, coagulation, and angiogenesis in early acute respiratory distress syndrome. Crit Care Med 2012, 40:495-501. 10.1097/CCM.0b013e318232da5e, 21983371.
35. Dixon WG, Abrahamowicz M, Beauchamp ME, Ray DW, Bernatsky S, Suissa S, Sylvestre MP. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis 2012, 71:1128-1133. 10.1136/annrheumdis-2011-200702, 3375584, 22241902.
36. Poetker DM, Reh DD. A comprehensive review of the adverse effects of systemic corticosteroids. Otolaryngol Clin North Am 2010, 43:753-768. 10.1016/j.otc.2010.04.003, 20599080.
37. Gattinoni L, Pelosi P, Suter PM, Pedoto A, Vercesi P, Lissoni A. Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?. Am J Respir Crit Care Med 1998, 158:3-11. 10.1164/ajrccm.158.1.9708031, 9655699.
38. Santos FB, Nagato LK, Boechem NM, Negri EM, Guimaraes A, Capelozzi VL, Faffe DS, Zin WA, Rocco PR. Time course of lung parenchyma remodeling in pulmonary and extrapulmonary acute lung injury. J Appl Physiol 2006, 100:98-106. 10.1152/japplphysiol.00395.2005, 16109834.
39. Lee N, Chan PK, Hui DS, Rainer TH, Wong E, Choi KW, Lui GC, Wong BC, Wong RY, Lam WY, Chu IM, Lai RW, Cockram CS, Sung JJ. Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis 2009, 200:492-500. 10.1086/600383, 19591575.
40. Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, Lee YJ, Lee HB, Lim CM, Koh Y. Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med 2011, 183:1207-1214. 10.1164/rccm.201101-0110OC, 21471084.
41. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, Kumar A, Lim M, Shindo N, Penn C, Nicholson KG. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010, 362:1708-1719.
42. Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della Porta R, Giorgio C, Blasi F, Umberger R, Meduri GU. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005, 171:242-248. 10.1164/rccm.200406-808OC, 15557131.
43. Casserly B, Gerlach H, Phillips GS, Lemeshow S, Marshall JC, Osborn TM, Levy MM. Low-dose steroids in adult septic shock: results of the Surviving Sepsis Campaign. Intensive Care Med 2012, 38:1946-1954. 10.1007/s00134-012-2720-z, 23064466.
44. Buttgereit F, Burmester GR, Lipworth BJ. Optimised glucocorticoid therapy: the sharpening of an old spear. Lancet 2005, 365:801-803. 10.1016/S0140-6736(05)17989-6, 15733723.